Gulf Navigation Holding PJSC (GULFNAV.AE)
AED 5.8
(-0.17%)
AED 5.8
(-0.17%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -6.32 Million | 28.48 Million | 145.03 Million | 35.35 Million | 38.93 Million | 6.69 Million |
| Net Income | 21.27 Million | 4.66 Million | 59.52 Million | -279.07 Million | -326.97 Million | -40 Million |
| Depreciation & Amortization | 36.72 Million | 41.46 Million | 40.04 Million | 46.84 Million | 67.93 Million | 53.91 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -28.39 Million | -31.42 Million | 13 Million | 412 Thousand | 6.19 Million | -21.37 Million |
| Other non-cash items | -35.92 Million | 13.77 Million | 32.46 Million | 267.17 Million | 291.77 Million | 14.15 Million |
| Investing Cash Flow | -243.36 Million | -2.42 Million | -18.32 Million | -828 Thousand | -35.27 Million | -479.11 Million |
| Investments in PPE | -40.45 Million | -1.51 Million | -18.32 Million | -3.11 Million | -35.48 Million | -82.63 Million |
| Acquisitions | 99.47 Million | -915 Thousand | - | 5.45 Million | 539 Thousand | -400 Million |
| Investment purchases | -378.42 Million | - | - | - | - | - |
| Sales/Maturities of investments | 76.03 Million | - | - | - | - | - |
| Other Investing Activities | -202.91 Million | - | - | -3.17 Million | -330 Thousand | 3.51 Million |
| Financing Cash Flow | 241.95 Million | -17.99 Million | -124.2 Million | -44.21 Million | -9.86 Million | 467.52 Million |
| Debt repayment | -141.35 Million | -222.99 Million | -154.51 Million | -103.49 Million | -282.87 Million | -64.58 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -47.35 Million | -3.33 Million | - | - | - | - |
| Common Stock Issuance | 202.4 Million | 5.11 Million | - | - | -344 Thousand | 467.54 Million |
| Other Financing Activities | 63.33 Million | 208.32 Million | 30.31 Million | 59.28 Million | 273.35 Million | 64.55 Million |
| Accounts receivables | -3.68 Million | -11.56 Million | 8.64 Million | 9.1 Million | 11.1 Million | -4 Million |
| Accounts payables | -23.59 Million | -20.15 Million | 8.8 Million | -6.06 Million | -8.79 Million | -15.88 Million |
| Inventory | -1.11 Million | 292 Thousand | -1.81 Million | 2.9 Million | 3.88 Million | -1.48 Million |
| Other working capital | -232 Thousand | -146 Thousand | -2.63 Million | -5.53 Million | -295 Thousand | -19.88 Million |
| Cash at beginning of period | 17.8 Million | 9.74 Million | 7.23 Million | 16.92 Million | 23.13 Million | 28.03 Million |
| Cash at end of period | 10.05 Million | 17.8 Million | 9.74 Million | 7.23 Million | 16.92 Million | 23.13 Million |
| Capital Expenditure | -40.45 Million | -1.51 Million | -18.32 Million | -3.11 Million | -35.48 Million | -82.63 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -7.74 Million | 8.06 Million | 2.5 Million | -9.68 Million | -6.2 Million | -4.9 Million |
| Free Cash Flow | -46.77 Million | 26.97 Million | 126.71 Million | 32.24 Million | 3.44 Million | -75.94 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -13.21 Million | -11.48 Million | 21.27 Million | -14.75 Million | 7.33 Million | 14.74 Million |
| Depreciation & Amortization | 6.52 Million | 5.53 Million | 36.72 Million | 22.19 Million | -2.49 Million | 6.93 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -9.34 Million | -1.92 Million | -28.39 Million | 7.5 Million | -22.11 Million | -2.49 Million |
| Other non-cash items | 23.75 Million | -9.23 Million | -35.92 Million | 5.33 Million | -11.81 Million | -16.55 Million |
| Investing Cash Flow | 37.72 Million | 2.05 Million | -243.36 Million | -71.12 Million | -257.41 Million | 85.17 Million |
| Investments in PPE | -2.19 Million | -21.08 Million | -40.45 Million | -35.54 Million | -4.9 Million | -85.17 Million |
| Acquisitions | - | - | 99.47 Million | -1000.00 | 4.9 Million | 99.47 Million |
| Investment purchases | - | - | -378.42 Million | -99.51 Million | -261.98 Million | -16.92 Million |
| Sales/Maturities of investments | 39.91 Million | 23.14 Million | 76.03 Million | 63.92 Million | 9.48 Million | 2.62 Million |
| Other Investing Activities | - | 23.14 Million | -202.91 Million | -30.67 Million | -4.9 Million | 85.17 Million |
| Financing Cash Flow | -5.4 Million | 2.33 Million | 241.95 Million | 123.24 Million | 209.02 Million | -83.92 Million |
| Debt repayment | -7.81 Million | -13.61 Million | -141.35 Million | -14.6 Million | -36.54 Million | -76.83 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -59.17 Million | -35.44 Million | -47.35 Million | -47.35 Million | -2.22 Million | - |
| Common Stock Issuance | - | - | 202.4 Million | -55.1 Million | 217.77 Million | 28.45 Million |
| Other Financing Activities | 61.57 Million | 30.14 Million | 63.33 Million | 63.33 Million | 30.02 Million | -35.54 Million |
| Accounts receivables | -27.88 Million | -2.12 Million | -3.68 Million | 29.97 Million | -10.46 Million | -7.09 Million |
| Accounts payables | 5.19 Million | 219 Thousand | -23.59 Million | -22.43 Million | -10.29 Million | 4.31 Million |
| Inventory | 1000.00 | -20 Thousand | -1.11 Million | -37 Thousand | -1.34 Million | 283 Thousand |
| Other working capital | 13.34 Million | 12.55 Million | -232 Thousand | -133 Thousand | - | - |
| Cash at beginning of period | 222.84 Million | 10.05 Million | 17.8 Million | -62.33 Million | 15.13 Million | 11.26 Million |
| Cash at end of period | 27.15 Million | 22.84 Million | 10.05 Million | 10.05 Million | -62.33 Million | 15.13 Million |
| Capital Expenditure | -2.19 Million | -21.08 Million | -40.45 Million | -35.54 Million | -4.9 Million | -85.17 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -195.69 Million | 12.78 Million | -7.74 Million | 72.39 Million | -77.47 Million | 3.87 Million |
| Free Cash Flow | -30.2 Million | -12.69 Million | -46.77 Million | -15.26 Million | -33.99 Million | -82.53 Million |
AARTIPHARM
SELAN
UNH
300347
000738
ULTP